Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-05 5:17 pm Purchase |
2025-05-29 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
SR One Capital Management, LLC | 4,615,384 5.400% |
4,615,384 (New Position) |
Filing History |
| 2025-06-04 4:32 pm Purchase |
2025-05-29 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Point72 Asset Management, L.P. | 4,401,659 5.100% |
4,401,659 (New Position) |
Filing History |
| 2025-05-30 4:35 pm Purchase |
2025-04-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Venrock Healthcare Capital Partners III, L.P. | 6,596,885 7.700% |
3,414,358 (+107.28%) |
Filing History |
| 2025-05-15 5:47 pm Sale |
2025-03-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Venrock Healthcare Capital Partners III, L.P. | 3,182,527 4.500% |
-1,245,858 (-28.13%) |
Filing History |
| 2025-05-15 4:35 pm Purchase |
2025-03-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
VIKING GLOBAL INVESTORS LP | 6,572,700 9.200% |
2,572,700 (+64.32%) |
Filing History |
| 2025-05-15 09:42 am Sale |
2025-03-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Frazier Life Sciences Public Fund, L.P. | 1,410,193 2.000% |
-2,732,662 (-65.96%) |
Filing History |
| 2025-02-12 09:30 am Sale |
2024-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR LLC | 2,467,809 3.500% |
-1,911,010 (-43.64%) |
Filing History |
| 2024-11-14 5:54 pm Sale |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital, LLC | 3,418,068 4.900% |
-2,857,142 (-45.53%) |
Filing History |
| 2024-11-14 5:47 pm Purchase |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Nextech Crossover I GP S.a r.l. | 5,285,714 7.500% |
1,000,000 (+23.33%) |
Filing History |
| 2024-11-14 5:14 pm Sale |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
The Column Group II, LP | 3,644,118 5.200% |
-27,404 (-0.75%) |
Filing History |
| 2024-11-13 09:42 am Purchase |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Alkeon Capital Management LLC | 3,904,096 5.500% |
300,000 (+8.32%) |
Filing History |
| 2024-11-12 10:32 am Sale |
2024-11-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR LLC | 4,378,819 6.207% |
-715,910 (-14.05%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
5,101,817 7.200% |
0 (Unchanged) |
Filing History |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
5,101,817 7.200% |
2,106,785 (+70.34%) |
Filing History |
| 2024-03-11 08:19 am Sale |
2024-03-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR LLC | 5,094,729 7.562% |
-1,907,379 (-27.24%) |
Filing History |
| 2024-02-14 6:19 pm Purchase |
2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital, LLC | 6,275,210 8.900% |
2,857,142 (+83.59%) |
Filing History |
| 2024-02-13 6:43 pm Purchase |
2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Alkeon Capital Management LLC | 3,604,096 6.600% |
1,204,844 (+50.22%) |
Filing History |
| 2024-02-13 09:26 am Sale |
2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Prosight Management LP | 1,578,263 2.900% |
-702,515 (-30.80%) |
Filing History |
| 2024-02-09 09:28 am Purchase |
2024-02-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR LLC | 7,002,108 12.835% |
2,985,500 (+74.33%) |
Filing History |
| 2024-02-07 5:09 pm Sale |
2024-01-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
BlackRock Inc. BLK |
2,995,032 4.500% |
-100,616 (-3.25%) |
Filing History |